Trimel Pharmaceuticals Corporation
TSX : TRL

Trimel Pharmaceuticals Corporation

October 29, 2014 17:05 ET

Trimel to Report Third Quarter 2014 Results and Host Conference Call to Update Investors

TORONTO, ONTARIO--(Marketwired - Oct. 29, 2014) - Trimel Pharmaceuticals Corporation (TSX:TRL) will report its third quarter financial results for the period ended September 30, 2014 on Thursday, November 6, 2014 before markets open.

Management of the Company will host a conference call to discuss these results and update investors on the status of its business on Friday, November 7, 2014 at 8:30 a.m. Eastern Standard Time. Following the discussion, Trimel executives will address inquiries from investment analysts.

To access the call live, please dial 416-340-2216 or 1-866-223-7781. Listeners are encouraged to dial in 10 minutes before the call begins to avoid delays.

A replay of the conference call will be available until 7:00 p.m. Eastern Standard Time on Friday, November 14, 2014 by dialing 905-694-9451 or 1-800-408-3053, using access code: 3455434#.

For further information regarding Trimel Pharmaceuticals Corporation, please contact Kenneth Howling, Chief Financial Officer at 416-679-0536 or via email at ir@trimelpharmaceuticals.com.

About Trimel

Trimel is a specialty pharmaceutical company actively developing medications for male hypogonadism, female sexual dysfunction and various respiratory disorders. Natesto™, a product utilizing Trimel's licensed bioadhesive nasal gel technology, has been approved for sale in the United States by the FDA. For more information, please visit www.trimelpharmaceuticals.com.

Contact Information